Oppenheimer raised the firm’s price target on Corteva (CTVA) to $86 from $78 and keeps an Outperform rating on the shares. The firm remains bullish on the shares as it believes Corteva have benefited from multiple expansion largely driven by the cyclical market rotation. Heading into the split, Oppenheimer believes near-term guidance offers a degree of conservatism against a still choppy global agriculture backdrop.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva price target raised to $85 from $77 at Wells Fargo
- Corteva price target raised to $88 from $78 at Goldman Sachs
- Corteva price target raised to $80 from $74 at Citi
- Corteva: Fairly Valued Ahead of 2026 Separation, Supporting a Neutral (Hold) Rating
- Corteva downgraded to Neutral from Overweight at JPMorgan
